The Claim

Population screening for ovarian cancer using CA125-based multimodal or ultrasound-only strategies should not be implemented in average-risk postmenopausal women because it does not reduce mortality and causes significant harm through unnecessary surgeries.

Source: Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial.

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
75score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Cause and effect
1 study reviewed
In plain English

Testing healthy older women for ovarian cancer with blood tests or ultrasounds doesn’t save lives and often leads to risky surgeries that aren’t needed — so it’s not worth doing.

See the scientific wording

Population screening for ovarian cancer using CA125-based multimodal or ultrasound-only strategies should not be implemented in average-risk postmenopausal women because it does not reduce mortality and causes significant harm through unnecessary surgeries.

What the research says

1 study

  1. Study: Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial.

    This big study checked if checking for ovarian cancer every year with blood tests or ultrasounds saves lives in healthy older women. It found it doesn’t save lives, but does cause many women to have unnecessary surgeries because of false alarms.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.